Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

US Patent 10918668 · Granted Feb 16, 2021

Estimated economic value: $41,014,000

Assignee

Inventors

View full patent text on Google Patents →